剪接体突变对骨髓增生异常综合征RNA剪接的影响:失调基因/通路及临床关联
该研究对84例骨髓增生异常综合征(MDS)患者的CD34+细胞进行RNA-seq,系统分析SF3B1、SRSF2和U2AF1突变对前体mRNA剪接的影响。剪接因子突变导致不同剪接改变和不同基因受累,但汇聚于RNA剪接、蛋白质合成和线粒体功能障碍等共同失调通路。研究还发现与临床变量相关的异常剪接事件及独立预测生存的异构体,并提示黏着斑和细胞外外泌体失调与不良生存相关。
要点
- 剪接因子突变对剪接的影响各异且主要累及不同基因,但汇聚于RNA剪接、蛋白质合成和线粒体功能障碍等共同通路。
- 鉴定出与临床变量相关的异常剪接事件及独立预测MDS生存的异构体,提示黏着斑和细胞外外泌体失调驱动不良生存。
- 敲低SF3B1和SRSF2突变异常剪接的靶基因SEPT2和AKAP8可导致红系细胞生长和分化受损。
核心结论
- 剪接因子突变在MDS中导致不同的剪接改变但汇聚于共同失调通路,揭示了其对MDS表型的影响并为疾病病理生理提供新见解。
研究设计与样本
- 对84例MDS患者的CD34+细胞进行RNA-seq,系统分析常见剪接因子突变对前体mRNA剪接的影响。
主要发现
- 剪接因子突变导致不同的剪接改变且主要影响不同基因,但汇聚于RNA剪接、蛋白质合成和线粒体功能障碍等共同失调通路。
- 鉴定出与临床变量相关的异常剪接事件以及独立预测MDS生存的异构体,并提示黏着斑和细胞外外泌体失调驱动不良生存。
- 敲低SF3B1和SRSF2突变分别异常剪接的靶基因SEPT2和AKAP8可导致红系细胞生长和分化受损。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SF3B1, SRSF2, and U2AF1 are the most frequently mutated splicing factor genes in the myelodysplastic syndromes (MDS). We have performed a comprehensive and systematic analysis to determine the effect of these commonly mutated splicing factors on pre-mRNA splicing in the bone marrow stem/progenitor cells and in the erythroid and myeloid precursors in splicing factor mutant MDS. Using RNA-seq, we determined the aberrantly spliced genes and dysregulated pathways in CD34+ cells of 84 patients with MDS. Splicing factor mutations result in different alterations in splicing and largely affect different genes, but these converge in common dysregulated pathways and cellular processes, focused on RNA splicing, protein synthesis, and mitochondrial dysfunction, suggesting common mechanisms of action in MDS. Many of these dysregulated pathways and cellular processes can be linked to the known disease pathophysiology associated with splicing factor mutations in MDS, whereas several others have not been previously associated with MDS, such as sirtuin signaling. We identified aberrantly spliced events associated with clinical variables, and isoforms that independently predict survival in MDS and implicate dysregulation of focal adhesion and extracellular exosomes as drivers of poor survival. Aberrantly spliced genes and dysregulated pathways were identified in the MDS-affected lineages in splicing factor mutant MDS. Functional studies demonstrated that knockdown of the mitosis regulators SEPT2 and AKAP8, aberrantly spliced target genes of SF3B1 and SRSF2 mutations, respectively, led to impaired erythroid cell growth and differentiation. This study illuminates the effect of the common spliceosome mutations on the MDS phenotype and provides novel insights into disease pathophysiology.
引用
- Pellagatti A, Armstrong RN, Steeples V, et al. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations. Blood. 2018. PMID: 29930011. doi:10.1182/blood-2018-04-843771
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。